{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.02, "exchange": "ASX", "shortName": "CRESO FPO", "longName": "Creso Pharma Limited", "messageBoardId": "finmb_377773214", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "marketState": "POSTPOST", "regularMarketPreviousClose": 0.02, "bid": 0.019, "ask": 0.02, "bidSize": 418163, "askSize": 968740, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.021, "averageDailyVolume3Month": 7375915, "averageDailyVolume10Day": 18517758, "fiftyTwoWeekLowChange": 0.011, "fiftyTwoWeekLowChangePercent": 1.2222222, "fiftyTwoWeekRange": "0.009 - 0.061", "fiftyTwoWeekHighChange": -0.041, "fiftyTwoWeekHighChangePercent": -0.6721312, "fiftyTwoWeekLow": 0.009, "fiftyTwoWeekHigh": 0.061, "earningsTimestamp": 1682679540, "earningsTimestampStart": 1682679540, "earningsTimestampEnd": 1682679540, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.03, "firstTradeDateMilliseconds": 1476918000000, "priceHint": 4, "sharesOutstanding": 2136509952, "bookValue": 0.012, "fiftyDayAverage": 0.01119, "fiftyDayAverageChange": 0.00881, "fiftyDayAverageChangePercent": 0.78731006, "twoHundredDayAverage": 0.0235725, "twoHundredDayAverageChange": -0.0035725012, "twoHundredDayAverageChangePercent": -0.15155376, "marketCap": 42740800, "priceToBook": 1.6666666, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.0, "regularMarketTime": 1683871827, "regularMarketDayHigh": 0.021, "regularMarketDayRange": "0.019 - 0.021", "regularMarketDayLow": 0.019, "regularMarketVolume": 3261155, "symbol": "CPH.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "145 Stirling Highway", "address2": "Suite 5 CPC", "city": "Nedlands", "state": "WA", "zip": "6009", "country": "Australia", "phone": "61 8 9389 3180", "fax": "61 8 9389 3199", "website": "https://www.cresopharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser. In addition, the company develops Halucenex, which is in phase II clinical trials, which will test the efficacy of psilocybin on treatment of resistant Post Traumatic Stress Disorder. Further, it engages in marketing of its hemp based food, feed supplements, and topical products; manufacture and sale of packaged consumer products; conducts clinical trial and development of synthetic psilocybin micro and macro dose formulations to treat treatment resistant depression and anxiety; and development of psychedelic medicines. The company was incorporated in 2015 and is headquartered in Nedlands, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Boaz  Wachtel M.A., M.D., MBA", "age": 61, "title": "Co-Founder & Non-Exec. Chairman", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 80000, "fmt": "80k", "longFmt": "80,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. William  Lay B.Com.", "title": "Group CEO, MD & Director", "fiscalYear": 2022, "totalPay": {"raw": 408495, "fmt": "408.5k", "longFmt": "408,495"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher  Grundy", "title": "Chief Financial Officer", "fiscalYear": 2022, "totalPay": {"raw": 314430, "fmt": "314.43k", "longFmt": "314,430"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Micheline  MacKay B.Sc., M.Sc., P.M.P.", "title": "Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 193007, "fmt": "193.01k", "longFmt": "193,007"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jodi  Scott M.Sc.", "title": "Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 88188, "fmt": "88.19k", "longFmt": "88,188"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gian  Trepp", "title": "Commercial & Marketing Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG", "title": "Joint Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom", "age": 52, "title": "Joint Company Sec.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Hon. Brian  Walker", "title": "Strategic Consultant & Chair of Scientific Advisory Committee", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}